DMS Group: Verso Capital increases its stake
(CercleFinance.com) - Diagnostic Medical Systems announces an increase in Verso Capital's stake in its capital, via the exercise of adjustment warrants, in accordance with the Solutions For Tomorrow acquisition agreement signed in October 2023.
On completion of this transaction, Verso Capital and its co-shareholder will hold 5,505,397 shares, representing 26.4% of DMS Group's capital. Verso Capital thus confirms its role as a key shareholder alongside the management team.
As a reminder, the acquisition of Solutions For Tomorrow is fully in line with the Imaging 2027 strategic plan, which aims to position DMS Group as a leading independent European medtech company.
Copyright (c) 2024 CercleFinance.com. All rights reserved.